The global brain implants market, valued at $7.10 billion in 2025, is projected to grow at a CAGR of 9.99% to reach $18.39 billion by 2035. Growth is fueled by advances in neurotechnology, including deep brain stimulation and brain-computer interfaces, which offer new treatments for Parkinson's, epilepsy, and other neurological disorders. North America leads the market, with the U.S. expected to reach $8.17 billion by 2035, supported by strong healthcare infrastructure and research funding. The Asia-Pacific region is the fastest-growing market due to rising neurological disease prevalence and expanding healthcare investments.
Abbott Laboratories shares have fallen from $127.12 to $90.53 due to sector-wide rotation and concerns over its $21 billion Exact Sciences acquisition. Despite this, its diabetes franchise, led by the FreeStyle Libre glucose monitor, and medical devi...
The global market for neonatal intensive care respiratory devices, valued at approximately $2.1 billion in 2025, is projected to grow to $5.7 billion by 2035 with a CAGR of 10.5%. Growth is driven by increased NICU expansions, rising preterm births, ...
